<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01432639</url>
  </required_header>
  <id_info>
    <org_study_id>PTDC/DES/113753/2009</org_study_id>
    <nct_id>NCT01432639</nct_id>
  </id_info>
  <brief_title>Effects of Exercise Training on Endothelial Function, Inflammation, Arterial Stiffness and Autonomic Function in CAD</brief_title>
  <official_title>Effects of Exercise Training on Endothelial Function, Inflammation, Arterial Stiffness and Autonomic Function in Coronary Artery Disease Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidade do Porto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Centro Hospitalar de Vila Nova de Gaia/Espinho</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Research Center in Physical Activity, Health and Leisure, Portugal</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universidade do Porto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main purposes of this study is to analyze, in a randomized controlled trial, the effects
      of an exercise-based cardiac rehabilitation program (i) on biomarkers of endothelial
      function, (ii) on biomarkers of inflammation, (iii) on autonomic function, and (iv) on
      arterial stiffness in coronary artery disease patients (CAD). Additionally, the investigators
      aim to analyze the (v) contribution of age and the changes in traditional risk factors to the
      modification of the endothelial dysfunction and inflammation, and (vi) the contribution of
      the changes in inflammatory and endothelial function biomarkers to the modification of
      autonomic function and arterial stiffness.

      The investigators hypothesize that exercise training will improve the autonomic function,
      arterial stiffness and mitigate the endothelial dysfunction and inflammation in CAD patients
      even in the absence of significant changes in traditional risk factors. Thus, the
      investigators expect with the present study to promote, develop and expand the knowledge in
      this field by assessing the impact of exercise on a pool of markers that provide a wide
      picture of the pathophysiological processes underlying CAD.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2011</start_date>
  <completion_date type="Actual">November 2012</completion_date>
  <primary_completion_date type="Actual">November 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Autonomic Function</measure>
    <time_frame>Change from Baseline in Autonomic Function at 8 weeks of Cardiac Rehabilitation Program</time_frame>
    <description>Autonomic function will be assessed by resting heart rate variability, heart rate recovery after maximal exercise and circulating levels of norepinephrine and epinephrine.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Arterial Stiffness</measure>
    <time_frame>Change from Baseline in Arterial Stiffness at 8 weeks of Cardiac Rehabilitation Program</time_frame>
    <description>Arterial Stiffness will be assessed by carotid-femoral pulse wave velocity and the aortic augmentation index.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endothelial Function</measure>
    <time_frame>Change from Baseline in Endothelial Function at 8 weeks of Cardiac Rehabilitation Program</time_frame>
    <description>Using commercially available assay kits (R&amp;D Systems, Minneapolis, MN, USA), the serum levels of sICAM-1 and sVCAM-1 will be measured in serum by an enzyme-linked immunosorbent assay (ELISA) according to the manufacturer's instructions and read at 450 nm using a microplate reader (Labsystems iEMS MF controlled by Ascent software v. 2.4, Dynex Labsystems).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiorespiratory Fitness</measure>
    <time_frame>Change from Baseline in Cardiorespiratory Fitness at 8 weeks of Cardiac Rehabilitation Program</time_frame>
    <description>Maximal or symptom-limited treadmill exercise testing will be conducted using the modified Bruce protocol.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammatory Biomarkers</measure>
    <time_frame>Change from Baseline in Inflammatory Biomarkers at 8 weeks of Cardiac Rehabilitation Program</time_frame>
    <description>Using commercially available assay kits (R&amp;D Systems, Minneapolis, MN, USA), the serum levels of CRP, IL-10 and IL-6 will be measured in serum by an enzyme-linked immunosorbent assay (ELISA) according to the manufacturer's instructions and read at 450 nm using a microplate reader (Labsystems iEMS MF controlled by Ascent software v. 2.4, Dynex Labsystems).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anthropometrics</measure>
    <time_frame>Change from Baseline in Anthropometrics at 8 weeks of Cardiac Rehabilitation Program</time_frame>
    <description>Height and weight measurements will be assessed using a standard wall-mounted stadiometer and portable digital beam scale (SECA, 708), respectively. Body mass index will be calculated from the ratio of weight (kg) to squared height (m2). Percentage of fat mass will be estimated by bioelectrical impedance analysis (BC-532, Tanita, Tokyo, Japan).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Pressure</measure>
    <time_frame>Change from Baseline in Blood Pressure at 8 weeks of Cardiac Rehabilitation Program</time_frame>
    <description>Resting systolic and diastolic blood pressure will be measured using a digital automatic blood pressure monitor (Omron Pressmate BP10, Omron Healthcare Co., Ltd, Kyoto, Japan).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dietary Intake</measure>
    <time_frame>Change from Baseline in Dietary Intake at 8 weeks of Cardiac Rehabilitation Program</time_frame>
    <description>Dietary intake will be assessed using a 4-day food diary as representative of the usual intake. Patients will be asked to provide detailed information concerning the food and beverages intake for four days (Sunday and 3-week days).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Daily Physical Activity</measure>
    <time_frame>Change from Baseline in Daily Physical Activity at 8 weeks of Cardiac Rehabilitation Program</time_frame>
    <description>Physical activity will be objectively measured for 7 consecutive days using the ActiGraph accelerometer (model GT1M, Florida, USA).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biochemical Parameters</measure>
    <time_frame>Change from Baseline in Biochemical Parameters at 8 weeks of Cardiac Rehabilitation Program</time_frame>
    <description>Fasting plasma glucose, total cholesterol, high-density lipoprotein cholesterol, triglycerides, and HbA1c will be measured by enzymatic methods (912 automatic analyzer, Roche Diagnostic, Basel, Switzerland). Low-density lipoprotein cholesterol will be calculated using the Friedewald equation, except if triglycerides &gt; 400 mg/dL.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">96</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>Experimental group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients undergoing the exercise-based cardiac rehabilitation program (intervention)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Usual medical care</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Exercise-based cardiac rehabilitation program</intervention_name>
    <description>The intervention consists of usual medical care (i.e., medicine prescription and counseling of lifestyle modifications) and an supervised outpatient aerobic exercise training, which will be performed 3 days per week for 8 weeks. Each exercise session include 10 min of warm up, 35 min of aerobic exercise (i.e., cycloergometer or treadmill) and 10 min of cool down. The exercise intensity will be calculated as 65- 75% of maximal heart rate achieved in the treadmill exercise testing. Individualized exercise prescription will be periodically adjusted. A perceived exertion scale will be used as an adjunctive intensity modulator. In addition, each patient will be encouraged to daily exercise outside the formal exercise program.</description>
    <arm_group_label>Experimental group</arm_group_label>
    <other_name>Cardiac rehabilitation program</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  acute myocardial infarction

        Exclusion Criteria:

          -  ventricular tachyarrhythmia

          -  uncontrolled hypertension (systolic blood pressure &gt;180 mmHg or diastolic blood
             pressure &gt;100 mmHg)

          -  significant valvular disease

          -  unstable angina pectoris

          -  reduced left ventricular function (ejection fraction &lt; 45%)

          -  abnormal hemodynamic response

          -  myocardial ischemia and/or severe ventricular arrhythmias during baseline exercise
             testing

          -  uncontrolled metabolic disease (e.g. uncontrolled diabetes or thyroid disease)

          -  presence of pulmonary and renal co-morbidities

          -  peripheral artery disease and/or orthopedic limitations
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jose Oliveira, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Research Center in Physical Activity, Health and Leisure, Portugal</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fernando Ribeiro, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Research Center in Physical Activity, Health and Leisure, Portugal</affiliation>
  </overall_official>
  <overall_official>
    <last_name>NÃ³rton L Oliveira, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Research Center in Physical Activity, Health and Leisure, Portugal</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Madalena Teixeira, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centro Hospitalar de Vila Nova de Gaia/Espinho</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centro Hospitalar de Vila Nova de Gaia/Espinho</name>
      <address>
        <city>Vila Nova de Gaia</city>
        <zip>4434-502</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Portugal</country>
  </location_countries>
  <reference>
    <citation>Ribeiro F, Alves AJ, Duarte JA, Oliveira J. Is exercise training an effective therapy targeting endothelial dysfunction and vascular wall inflammation? Int J Cardiol. 2010 Jun 11;141(3):214-21. doi: 10.1016/j.ijcard.2009.09.548. Epub 2009 Nov 6. Review.</citation>
    <PMID>19896741</PMID>
  </reference>
  <reference>
    <citation>Graham LN, Smith PA, Stoker JB, Mackintosh AF, Mary DA. Time course of sympathetic neural hyperactivity after uncomplicated acute myocardial infarction. Circulation. 2002 Aug 13;106(7):793-7.</citation>
    <PMID>12176949</PMID>
  </reference>
  <reference>
    <citation>Laing ST, Gluckman TJ, Weinberg KM, Lahiri MK, Ng J, Goldberger JJ. Autonomic effects of exercise-based cardiac rehabilitation. J Cardiopulm Rehabil Prev. 2011 Mar-Apr;31(2):87-91. doi: 10.1097/HCR.0b013e3181f1fda0.</citation>
    <PMID>20861747</PMID>
  </reference>
  <reference>
    <citation>Sandercock GR, Grocott-Mason R, Brodie DA. Changes in short-term measures of heart rate variability after eight weeks of cardiac rehabilitation. Clin Auton Res. 2007 Feb;17(1):39-45. Epub 2007 Feb 6.</citation>
    <PMID>17285225</PMID>
  </reference>
  <reference>
    <citation>Weber T, Auer J, O'rourke MF, Kvas E, Lassnig E, Lamm G, Stark N, Rammer M, Eber B. Increased arterial wave reflections predict severe cardiovascular events in patients undergoing percutaneous coronary interventions. Eur Heart J. 2005 Dec;26(24):2657-63. Epub 2005 Sep 23.</citation>
    <PMID>16183688</PMID>
  </reference>
  <reference>
    <citation>Edwards DG, Schofield RS, Magyari PM, Nichols WW, Braith RW. Effect of exercise training on central aortic pressure wave reflection in coronary artery disease. Am J Hypertens. 2004 Jun;17(6):540-3.</citation>
    <PMID>15177529</PMID>
  </reference>
  <reference>
    <citation>Psychari SN, Apostolou TS, Iliodromitis EK, Kourakos P, Liakos G, Kremastinos DT. Inverse relation of C-reactive protein levels to heart rate variability in patients after acute myocardial infarction. Hellenic J Cardiol. 2007 Mar-Apr;48(2):64-71.</citation>
    <PMID>17489343</PMID>
  </reference>
  <reference>
    <citation>Chesterton LJ, Sigrist MK, Bennett T, Taal MW, McIntyre CW. Reduced baroreflex sensitivity is associated with increased vascular calcification and arterial stiffness. Nephrol Dial Transplant. 2005 Jun;20(6):1140-7. Epub 2005 Apr 12.</citation>
    <PMID>15827047</PMID>
  </reference>
  <verification_date>June 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 7, 2011</study_first_submitted>
  <study_first_submitted_qc>September 9, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 13, 2011</study_first_posted>
  <last_update_submitted>June 5, 2013</last_update_submitted>
  <last_update_submitted_qc>June 5, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 6, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidade do Porto</investigator_affiliation>
    <investigator_full_name>Jose Manuel Fernandes Oliveira</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Myocardial infarction</keyword>
  <keyword>Autonomic function</keyword>
  <keyword>Arterial Stiffness</keyword>
  <keyword>Endothelial function</keyword>
  <keyword>Inflammation</keyword>
  <keyword>Rehabilitation program</keyword>
  <keyword>Exercise</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Arteritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

